• FDA clears BioSig system for high-fidelity heart rhythm exams fiercebiotech
    August 15, 2018
    BioSig Technologies received a 510(k) clearance from the FDA for its first product, the PURE EP system, a noninvasive platform for digitizing and analyzing electrocardiographic and intracardiac signals for patients undergoing electrophysiology procedures.
PharmaSources Customer Service